Related resources
KN1 Beyond effectiveness: research on vaccines seen as a continuum
KN2 National and regional capacity for biotechnology research; Indian experience
P1 Progress Towards and Commonalities in Vaccine Development Against HIV, TB, and Malaria
P1.1 Advanced Clinical Development of HIV Vaccines
P1.4 Global Pipeline for Malaria Vaccines: Progress and Challenges to accelerate vaccine development
P5 Evidence for Decision Making
Robert Breiman (Emory University), Suresh Jadhav (Serum Institute of India), Gagandeep Kang (Christian Medical College, Vellore), David Kaslow (PATH), Yot Teerawattanaon (Health Intervention and Technology Assessment Program, MoPH Thailand), Anita Zaidi (Bill & Melinda Gates Foundation), Jean-Antoine Zinsou (International Federation of Pharmaceutical Manufacturers Associations)
